Currently, there aren’t any pharmaceutical drugs approved for the treatment of binge eating disorder. However, the findings of recent preliminary research out of the US suggests this could potentially change in the near future.
According to the study, published in the journal JAMA Psychiatry, a medication used to treat attention-deficit/hyperactivity disorder (AD/HD) may also be effective in treating binge eating disorder – a serious condition that causes sufferers to eat large amounts of food uncontrollably, without purging or over-exercising afterwards.
Over a period of 14 weeks, around 260 people with moderate to severe binge eating disorder were monitored. They were broken into four groups for the first 11 weeks – three groups were given varying doses of the AD/HD drug Vyvanese, while the fourth took placebo pills.
Those using the higher doses of Vyvanese (50mg and 70mg) reported a bigger reduction in the number of days they binged per week than those in the placebo group.
Furthermore, almost half of the participants in the 50mg dose group and 70mg dose group were able to stop bingeing for a month. Only a fifth of those using the placebo pills were about to do the same.